- Citations, last 5 years
- 472
- Works, last 5 years
- 47
- h-index
- 45
- Scientists listed
- 4
- Grants since 2016
- 4
Grants received
2021–2023 · research · R44
Development of a novel analgesic for mixed inflammatory and neuropathic pain states
Andrea Ghetti · AnaBios (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of a novel translational pain-drug screening platform for the generation of human-relevant data in preclinical pain drug discovery
Andrea Ghetti · AnaBios (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Development of an Integrated Platform for the Use of Adult Human Primary Cardiomyocytes in Preclinical Safety Assessment
Najah Abi Gerges · AnaBios (United States) · funded by National Institutes of Health
2019–2021 · cooperative agreement · U01
DEVELOPMENT AND QUALIFICATION OF A BIOMARKER FOR PRECLINICALLY IDENTIFYING THE PRO-ARRHYTHMIA RISK OF DRUGS BASED ON CONTRACTILITY MEASUREMENTS CONDUCTED IN HUMAN ADULT PRIMARY CARDIOMYOCYTES
Najah Abi Gerges · AnaBios (United States) · funded by U.S. Food and Drug Administration